早期宫颈癌初次根治性子宫切除术前宫颈锥切对疾病复发具有保护作用:一项按手术入路匹配的两中心队列研究
本研究基于两个机构2009 FIGO IB1期宫颈癌队列,比较根治性子宫切除术前接受宫颈锥切(144例)与对照组(434例)的生存结局,按手术入路行倾向评分匹配。匹配后锥切组无病生存显著优于对照组(3年DFS率94.2% vs 86.3%,P=0.012),总体生存相似;该优势仅见于微创手术亚组(3年DFS率95.7% vs 82.9%,P=0.005),开腹手术亚组无差异(P=0.984)。
要点
- 匹配后锥切组3年无病生存率94.2%,对照组86.3%(P=0.012),总体生存相似。
- 微创根治性子宫切除匹配患者中,锥切组3年DFS率95.7% vs 对照组82.9%(P=0.005)。
- 开腹根治性子宫切除匹配患者中,锥切组与对照组DFS无差异(P=0.984)。
核心结论
- 术前宫颈锥切可能降低接受初次微创根治性子宫切除术的早期宫颈癌患者的疾病复发率。
研究设计与样本
- 两中心匹配队列研究,纳入2009 FIGO IB1期、淋巴结阴性、切缘阴性、宫旁阴性并接受初次Type C根治性子宫切除术的患者,手术时间为2006年7月至2020年6月。
- 锥切组144例,对照组434例;按组织学、淋巴血管间隙浸润、宫颈肿瘤大小和手术入路进行三次独立的1:1倾向评分匹配(全部患者、开腹手术者、微创手术者)。
主要发现
- 总体锥切组宫颈肿瘤尺寸更小、接受微创手术更频繁(P=0.010)、接受辅助治疗更少(P=0.002)。
- 匹配后锥切组无病生存显著优于对照组(3年DFS率94.2% vs 86.3%;P=0.012),总体生存相似。
- 开腹根治性子宫切除匹配患者(n=96)中,锥切组与对照组DFS无差异(P=0.984)。
- 微创根治性子宫切除匹配患者(n=192)中,锥切组DFS显著优于对照组(3年DFS率95.7% vs 82.9%;P=0.005)。
- 调整宫颈肿瘤大小和辅助治疗后多因素分析显示,锥切是DFS的独立有利预后因素(校正HR 0.318;95%CI 0.134-0.754;P=0.009)。
关键数值与推荐
- 匹配后全部患者3年DFS率:锥切组94.2% vs 对照组86.3%(P=0.012)。
- 微创手术匹配患者3年DFS率:锥切组95.7% vs 对照组82.9%(P=0.005)。
- 多因素分析校正HR 0.318(95%CI 0.134-0.754;P=0.009)。
临床怎么用
- 原文结论为术前宫颈锥切可能降低接受初次微创根治性子宫切除术的早期宫颈癌患者的疾病复发率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To ascertain whether cervical conization before radical hysterectomy (RH) has a protective effect on survival outcomes in early cervical cancer, taking into account the surgical approach. METHODS: From cervical cancer cohorts of two institutions, we identified node-negative, margin-negative, parametria-negative, 2009 FIGO stage IB1 cervical cancer patients who received primary Type C RH between July 2006 and June 2020. Patients were divided into conization group (n = 144) and control group (n = 434). We conducted three independent 1:1 propensity score matching processes for histology, lymphovascular space invasion, cervical tumor size, and surgical approach (all patients, those who underwent open surgery, and those who underwent minimally invasive surgery [MIS]). Survival outcomes were compared. RESULTS: Overall, the conization group had less cervical tumor size and received MIS more frequently (P = 0.010) and adjuvant treatment less often (P = 0.002) versus the controls. After matching, the conization group showed significantly better disease-free survival (DFS) versus control (3-year DFS rate, 94.2% vs. 86.3%; P = 0.012), but similar overall survival. Among the open RH matched patients (n = 96), no difference in DFS was observed between the conization and control groups (P = 0.984). In contrast, among the MIS RH matched patients (n = 192), the conization group showed significantly better DFS versus control (3-year DFS rate, 95.7% vs. 82.9%; P = 0.005). In multivariate analysis adjusting for cervical tumor size and adjuvant treatment, conization was identified as an independent favorable prognostic factor for DFS (adjusted HR, 0.318; 95% CI, 0.134-0.754; P = 0.009). CONCLUSIONS: Preoperative cervical conization might reduce the disease recurrence rate in early cervical cancer patients who undergo primary MIS RH.
引用
- Kim SI, Choi BR, Kim HS, et al. Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approach. Gynecol Oncol. 2021. PMID: 34969535. doi:10.1016/j.ygyno.2021.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。